BSE : 534532
NSE : LYPSAGEMS
Sector :Others
ISIN Code : INE142K01011
NSE
7.64
0.14 (1.87%)
BSE
7.63
0.17 (2.28%)
04:01 PM,19th Dec 2024
Board of directors-1.Considered and approved Unaudited Standalone and Consolidated Financial Results for the Quarter ended on September 30 2024 along with Limited Review Report issued by the statutory auditors. Copy of Unaudited Standalone and Consolidated Financial Results along with Limited Review Report for the quarter ended September 30 2024 is attached herewith.2.Reviewed the disclosure of the Related party Transactions for the quarter ended September 30 2024.3.Reviewed the other business of the company